TrialHaematologica2011

Clinical effect of increasing doses of lenalidomide in high-risk myelodysplastic syndrome and acute myeloid leukemia with chromosome 5 abnormalities.

Lars Möllgård et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.